Retour d’expérience sur l’utilisation du belimumab en conditions réelles dans le cadre du traitement de patients lupiques
Florence Scher(Hôpitaux Universitaires de Strasbourg), B. Gourieux, Christelle Sordet, Emmanuel Chatelus(Laboratoire National de Référence), Jacques‐Eric Gottenberg(Centre National de la Recherche Scientifique), Laurent Arnaud, Guillaume Meyer, Julien Godet, Thierry Martin, Marion Fourtage
Cited by 0
Related Papers
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207
X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome
|Arthritis & Rheumatology|2015|176
Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study
|Annals of the Rheumatic Diseases|2015|165